Analyzing the forecast for liver malignant neoplasms mortality among women in Brazil from 2024 to 2028, we observe a steady annual increase in mortality rates, from 7.0 to 7.4 deaths per hundred thousand women. This shows a consistent year-on-year growth of approximately 1.43% over the period. A Compound Annual Growth Rate (CAGR) analysis over these years indicates a slight but persistent increase, reflecting an ongoing upward trend.
Future trends to watch for include the potential impact of healthcare advances in early detection and treatment of liver cancer, changes in risk factors such as hepatitis infection rates, and public health initiatives targeting prevention and awareness, each of which can influence these forecasted mortality rates.
